The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.25
Bid: 35.00
Ask: 35.50
Change: 0.00 (0.00%)
Spread: 0.50 (1.429%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 35.25
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendments to Investment Management Agreement

11 Jun 2009 07:00

RNS Number : 7053T
China Real Estate Opportunities PLC
11 June 2009
 



11 June 2009

CHINA REAL ESTATE OPPORTUNITIES PLC

Amendments to Investment Management Agreement

The Board of China Real Estate Opportunities plc announces that, following a review of the investment advisory agreement, dated 25 June 2007, between the Company and Treasury Holdings China Limited (the "Investment Manager"), the following amendments to the terms of that agreement have been agreed. These changes will eliminate from any future performance fee calculation (i) any increase in the value of RMB against Sterling; and (ii) any increase in net asset value per share arising from the Company repurchasing its shares. 

For the purposes of calculating any future entitlement to performance fees:

the European Public Real Estate Association net asset value at the end of each financial period will be restated in RMB. The payment of a performance fee remains subject to a high water mark which will initially be determined by reference to the Company's net assets as at 31 December 2008 expressed in RMB at the exchange rate prevailing on that date;

2. if the Company repurchases its own shares during any relevant period, the net asset value

per share at the end of that period will be adjusted so as to eliminate the impact of the

share repurchases on net asset value per share.

At the same time as agreeing the above the Board has taken the opportunity to tie the Investment Manager to the contract for a further two years so that, except in certain specified circumstances, the earliest date on which notice may be given will be in July 2012. 

These amendments are effective from 1 January 2009. The other terms of the investment advisory agreement remain unchanged.

- ENDS -

Contact:

CREO

Ray Horney, Chairman

Tel: + 44 (0)1273 775225

Sarah Moriarty, Investor Relations 

Tel: +353 1 6189455

Matrix Corporate CapitalPaul Fincham

Tel +44 (0) 20 3206 7000

Davy

Des Carville

Tel: +353 1 679 6363

Bankside Consultants

Simon Rothschild, Oliver Winters

Tel: + 44 (0)20 7367 8888

Murray Consultants

Ed Micheau

Tel: + 3531 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRSFWFISSUSEDM
Date   Source Headline
7th May 20207:00 amRNSFinal Results
23rd Mar 20207:00 amRNSFDA Clearance for HS1 Haemostasis Device
20th Mar 20207:00 amRNSTrading update – COVID-19 impact
4th Mar 20205:00 pmRNSExercise of Options
24th Feb 20203:49 pmRNSHolding(s) in Company
19th Feb 20207:00 amRNSLTIP Awards and Issue of Equity
11th Feb 20207:00 amRNSVideo abstracts re. Speedboat procedures in India
7th Feb 202011:50 amRNSExercise of Options
6th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
3rd Feb 20207:00 amRNSAppointment of NED
30th Jan 20207:00 amRNSTrading update
30th Dec 20193:17 pmRNSHolding(s) in Company
27th Dec 20195:00 pmRNSHolding(s) in Company
24th Dec 20198:01 amRNSDirector/PDMR Shareholding
23rd Dec 201911:15 amRNSResult of General Meeting and Total Voting Rights
23rd Dec 20197:00 amRNSResult of Open Offer
4th Dec 20197:00 amRNSRe. Placing, Open Offer, and Posting of Circular
2nd Dec 20197:00 amRNSFundraising and Launch of Accelerated Book Build
20th Nov 20197:00 amRNSFirst in-human cases in India
22nd Oct 20197:00 amRNSCommercial Launch of Speedboat at UEG Week
17th Oct 20197:00 amRNSUK Endoscopy Training Course
30th Sep 20197:00 amRNSHalf-year Report
26th Sep 20197:00 amRNSFramework Distribution Agreement for India
23rd Sep 20192:16 pmRNSNotice of Results
10th Sep 20197:00 amRNSUS Clinical Education Programme enters Phase II
7th Aug 20191:57 pmRNSDirector/PDMR Shareholding
5th Jul 20197:00 amRNSInstitute of Physics Award
25th Jun 20197:00 amRNSFirst commercial orders for Speedboat
6th Jun 20191:23 pmRNSResult of AGM
13th May 201910:50 amRNSAnnual Reports & Accounts & Notice of AGM
10th May 20197:00 amRNSMello 2019
24th Apr 20197:00 amRNSNew video abstract featuring Speedboat published
5th Apr 20197:00 amRNSFinal Results
28th Mar 20197:00 amRNSUpdate on US Clinical Education Programme
21st Mar 20192:34 pmRNSExercise of Options
21st Mar 20197:00 amRNSNotice of results and investor briefing
18th Mar 20197:00 amRNSCreo founder in Sunday Times 100 UK entrepreneurs
14th Mar 20195:17 pmRNSHolding(s) in Company
12th Mar 20199:19 amRNSSpeedboat in BSG Endoscopy best video abstract
6th Mar 201912:58 pmRNSExercise of Options
11th Feb 20197:00 amRNSDistribution agreement for France, Germany, Italy
24th Jan 201911:17 amRNSGrowth & Innovation Forum 2019
16th Jan 20197:00 amRNSFirst use of Speedboat in the US
17th Dec 20184:28 pmRNSExercise of Options
3rd Dec 20187:00 amRNSFirst placement and use of Speedboat in Europe
23rd Nov 201810:43 amRNSDirector/PDMR Shareholding
19th Nov 20181:30 pmRNSExercise of Options
22nd Oct 20182:52 pmRNSHolding(s) in Company
19th Oct 20187:00 amRNSUK Endoscopy Training Course
17th Oct 20187:00 amRNSSpain & Benelux Framework Distribution Agreements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.